Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Children’s Cancer and Blood Disorders program achieves outcomes that rank among the top national programs and cares for more than two-thirds of Minnesota children and adolescents with blood disorders. Care for sickle cell disease and hemoglobinopathies is provided through a division of the Cancer and Blood Disorders program called Children’s hemoglobinopathy and sickle cell program. Through this program, families have access to the newest and most promising treatments and receive care spearheaded and coordinated by a board-certified hematologist/oncologist.
The Hemoglobinopathy and Sickle Cell Program at Children’s aims to address each patient’s specific needs. Through a multidisciplinary health care team, access to the most current diagnostic tools like Transcranial Doppler (technology used to help identify and prevent strokes in children and teens with sickle cell disease), the specially designed C.H. Robinson Infusion Center, preventative therapies, and groundbreaking clinical research, the Children’s program is unlike any other treatment option in the region.
Related Content
-
Healthy red blood cells owe their shape to muscle-like structuresRed blood cells are on a wild ride. As t...
-
Children’s Hospital Oakland Research InstituteDuring our first 50 years, Children’s ...
-
Sickle cell disease in childrenSickle cell disease (SCD) is an inherite...
-
Sickle Cell Disease Program at Children’s HealthThe Sickle Cell Disease Program at Child...
-
David Beidler, PhDAs the Translational Sciences lead for t...
-
Maria Grazia Roncarolo, MDMaria Grazia Roncarolo, MD is the co-dir...
-
Sancilio Pharmaceuticals Company, Inc. (SPCI) Receives Rare Pediatric Disease Designation From the US Food and Drug ...Sancilio Pharmaceuticals Company, Inc. (...